Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Atkinson

Showing results (1501-1510 of 1,523) with videos related to

Pageof 153
Sort By:
Journal of Medicinal Chemistry|March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A InhibitorsStephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Nature Communications|September 27, 2022
Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearanceXu Zhang, Vesselina M Pearsall, Chase M Carver, et al.
Physical Review Letters|September 17, 2016
Proton Distribution Radii of ^{12-19}C Illuminate Features of Neutron HalosR Kanungo, W Horiuchi, G Hagen, et al.
Nature Chemical Biology|January 27, 2015
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formationHuw D Lewis, John Liddle, Jim E Coote, et al.
Physical Review Letters|October 14, 2022
Proton Distribution Radii of ^{16-24}O: Signatures of New Shell Closures and Neutron SkinS Kaur, R Kanungo, W Horiuchi, et al.
Science (New York, N.Y.)|June 9, 2021
Senolytics reduce coronavirus-related mortality in old miceChristina D Camell, Matthew J Yousefzadeh, Yi Zhu, et al.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Journal of Medicinal Chemistry|January 7, 2022
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral CandidatePhilip G Humphreys, Stephen J Atkinson, Paul Bamborough, et al.
Human Molecular Genetics|September 1, 2012
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsBrian D Juran, Gideon M Hirschfield, Pietro Invernizzi, et al.
Journal of Hepatology|May 25, 2021
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugsHeather J Cordell, James J Fryett, Kazuko Ueno, et al.
Pageof 153

Showing results (1501-1510 of 1,523) with videos related to

Sort By:
Pageof 153
Journal of Medicinal Chemistry|March 11, 2024
Development of a Series of Pyrrolopyridone MAT2A InhibitorsStephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, et al.
Nature Communications|September 27, 2022
Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearanceXu Zhang, Vesselina M Pearsall, Chase M Carver, et al.
Physical Review Letters|September 17, 2016
Proton Distribution Radii of ^{12-19}C Illuminate Features of Neutron HalosR Kanungo, W Horiuchi, G Hagen, et al.
Nature Chemical Biology|January 27, 2015
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formationHuw D Lewis, John Liddle, Jim E Coote, et al.
Physical Review Letters|October 14, 2022
Proton Distribution Radii of ^{16-24}O: Signatures of New Shell Closures and Neutron SkinS Kaur, R Kanungo, W Horiuchi, et al.
Science (New York, N.Y.)|June 9, 2021
Senolytics reduce coronavirus-related mortality in old miceChristina D Camell, Matthew J Yousefzadeh, Yi Zhu, et al.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Journal of Medicinal Chemistry|January 7, 2022
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral CandidatePhilip G Humphreys, Stephen J Atkinson, Paul Bamborough, et al.
Human Molecular Genetics|September 1, 2012
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsBrian D Juran, Gideon M Hirschfield, Pietro Invernizzi, et al.
Journal of Hepatology|May 25, 2021
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugsHeather J Cordell, James J Fryett, Kazuko Ueno, et al.
Pageof 153